{"podcast":{"title":"The Readout Loud","slug":"the-readout-loud-1134305","podcast_index_feed_id":1134305,"rss_url":"https://feeds.megaphone.fm/thereadoutloud","website_url":"https://soundcloud.com/readout-loud","image_url":"https://megaphone.imgix.net/podcasts/2700b5c2-6d26-11ee-87eb-1f9099431c15/image/517bb4949d560305bb39448edbb32d7a.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress","author":"STAT","episode_count":414,"summary":"STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.","last_synced_at":"2026-07-17T08:20:19.054206+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305"},"episodes":[{"title":"409: Predicting biotech clinical trials & a new Alzheimer's drug controversy","slug":"409-predicting-biotech-clinical-trials-a-new-alzheimer-s-drug-controversy","published_at":"2026-07-16T20:01:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/409-predicting-biotech-clinical-trials-a-new-alzheimer-s-drug-controversy","url":"https://traffic.megaphone.fm/TTSAA9068866669.mp3","duration_seconds":2132,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/409-predicting-biotech-clinical-trials-a-new-alzheimer-s-drug-controversy/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/409-predicting-biotech-clinical-trials-a-new-alzheimer-s-drug-controversy.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"408: Whistleblower takes on health insurance and FDA commissioner candidates","slug":"408-whistleblower-takes-on-health-insurance-and-fda-commissioner-candidates","published_at":"2026-07-09T20:05:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/408-whistleblower-takes-on-health-insurance-and-fda-commissioner-candidates","url":"https://traffic.megaphone.fm/TTSAA2387995576.mp3","duration_seconds":2638,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/408-whistleblower-takes-on-health-insurance-and-fda-commissioner-candidates/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/408-whistleblower-takes-on-health-insurance-and-fda-commissioner-candidates.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"407: The mysterious case of Eli Lilly's obesity drug","slug":"407-the-mysterious-case-of-eli-lilly-s-obesity-drug","published_at":"2026-06-25T18:55:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/407-the-mysterious-case-of-eli-lilly-s-obesity-drug","url":"https://traffic.megaphone.fm/TTSAA8014095271.mp3","duration_seconds":2565,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/407-the-mysterious-case-of-eli-lilly-s-obesity-drug/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/407-the-mysterious-case-of-eli-lilly-s-obesity-drug.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises","slug":"406-new-hope-in-treating-huntington-s-disease-and-a-report-card-on-rfk-jr-s-promises","published_at":"2026-06-18T19:39:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/406-new-hope-in-treating-huntington-s-disease-and-a-report-card-on-rfk-jr-s-promises","url":"https://traffic.megaphone.fm/TTSAA4011922611.mp3","duration_seconds":2170,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/406-new-hope-in-treating-huntington-s-disease-and-a-report-card-on-rfk-jr-s-promises/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/406-new-hope-in-treating-huntington-s-disease-and-a-report-card-on-rfk-jr-s-promises.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"405: An obesity drug deep-dive, and peptides move mainstream","slug":"405-an-obesity-drug-deep-dive-and-peptides-move-mainstream","published_at":"2026-06-11T20:24:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/405-an-obesity-drug-deep-dive-and-peptides-move-mainstream","url":"https://traffic.megaphone.fm/TTSAA8579876573.mp3","duration_seconds":2186,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/405-an-obesity-drug-deep-dive-and-peptides-move-mainstream/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/405-an-obesity-drug-deep-dive-and-peptides-move-mainstream.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"404: What RevMed's pancreatic cancer drug meant for one patient","slug":"404-what-revmed-s-pancreatic-cancer-drug-meant-for-one-patient","published_at":"2026-06-04T20:17:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/404-what-revmed-s-pancreatic-cancer-drug-meant-for-one-patient","url":"https://traffic.megaphone.fm/TTSAA4075545052.mp3","duration_seconds":2269,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/404-what-revmed-s-pancreatic-cancer-drug-meant-for-one-patient/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/404-what-revmed-s-pancreatic-cancer-drug-meant-for-one-patient.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"403: Biotech exec Jeremy Levin on the industry's strategic turning point","slug":"403-biotech-exec-jeremy-levin-on-the-industry-s-strategic-turning-point","published_at":"2026-05-28T18:16:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/403-biotech-exec-jeremy-levin-on-the-industry-s-strategic-turning-point","url":"https://traffic.megaphone.fm/TTSAA7370303095.mp3","duration_seconds":2842,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/403-biotech-exec-jeremy-levin-on-the-industry-s-strategic-turning-point/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/403-biotech-exec-jeremy-levin-on-the-industry-s-strategic-turning-point.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"402: Guarding biotech from China and big bets in longevity","slug":"402-guarding-biotech-from-china-and-big-bets-in-longevity","published_at":"2026-05-21T18:47:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/402-guarding-biotech-from-china-and-big-bets-in-longevity","url":"https://traffic.megaphone.fm/TTSAA3656178567.mp3","duration_seconds":2648,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/402-guarding-biotech-from-china-and-big-bets-in-longevity/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/402-guarding-biotech-from-china-and-big-bets-in-longevity.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"401: Makary’s departure and Cassidy’s tenuous Senate seat","slug":"401-makary-s-departure-and-cassidy-s-tenuous-senate-seat","published_at":"2026-05-14T20:11:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/401-makary-s-departure-and-cassidy-s-tenuous-senate-seat","url":"https://traffic.megaphone.fm/TTSAA2873727963.mp3","duration_seconds":2443,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/401-makary-s-departure-and-cassidy-s-tenuous-senate-seat/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/401-makary-s-departure-and-cassidy-s-tenuous-senate-seat.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"400:  Seaport's IPO adventure, obesity pill battles, and Makary's troubles","slug":"400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles","published_at":"2026-05-07T18:12:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles","url":"https://traffic.megaphone.fm/TTSAA3808177194.mp3?updated=1778178131","duration_seconds":1989,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"399: Hair-raising trial results, and Servier’s M&A wishlist","slug":"399-hair-raising-trial-results-and-servier-s-m-a-wishlist","published_at":"2026-04-30T19:42:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/399-hair-raising-trial-results-and-servier-s-m-a-wishlist","url":"https://traffic.megaphone.fm/TTSAA7086068693.mp3?updated=1777578856","duration_seconds":2486,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/399-hair-raising-trial-results-and-servier-s-m-a-wishlist/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/399-hair-raising-trial-results-and-servier-s-m-a-wishlist.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"398: A CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts","slug":"398-a-car-t-biotech-s-dramatic-turnaround-and-drugmakers-tactics-to-drive-more-scripts","published_at":"2026-04-23T20:54:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/398-a-car-t-biotech-s-dramatic-turnaround-and-drugmakers-tactics-to-drive-more-scripts","url":"https://traffic.megaphone.fm/TTSAA6592352327.mp3?updated=1777409428","duration_seconds":2270,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/398-a-car-t-biotech-s-dramatic-turnaround-and-drugmakers-tactics-to-drive-more-scripts/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/398-a-car-t-biotech-s-dramatic-turnaround-and-drugmakers-tactics-to-drive-more-scripts.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"397: A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment","slug":"397-a-pancreatic-cancer-breakthrough-and-new-hope-for-an-off-the-shelf-car-t-treatment","published_at":"2026-04-16T19:36:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/397-a-pancreatic-cancer-breakthrough-and-new-hope-for-an-off-the-shelf-car-t-treatment","url":"https://traffic.megaphone.fm/TTSAA1479018226.mp3","duration_seconds":2987,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/397-a-pancreatic-cancer-breakthrough-and-new-hope-for-an-off-the-shelf-car-t-treatment/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/397-a-pancreatic-cancer-breakthrough-and-new-hope-for-an-off-the-shelf-car-t-treatment.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"396: A new trick for old science, and biotech VCs' scrambled playbook","slug":"396-a-new-trick-for-old-science-and-biotech-vcs-scrambled-playbook","published_at":"2026-04-09T18:41:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/396-a-new-trick-for-old-science-and-biotech-vcs-scrambled-playbook","url":"https://traffic.megaphone.fm/TTSAA5523666345.mp3?updated=1775766569","duration_seconds":1932,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/396-a-new-trick-for-old-science-and-biotech-vcs-scrambled-playbook/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/396-a-new-trick-for-old-science-and-biotech-vcs-scrambled-playbook.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"395: Biotech investors' plea to Trump, and a busy M&A week","slug":"395-biotech-investors-plea-to-trump-and-a-busy-m-a-week","published_at":"2026-04-02T19:24:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/395-biotech-investors-plea-to-trump-and-a-busy-m-a-week","url":"https://traffic.megaphone.fm/TTSAA6976080442.mp3?updated=1775158295","duration_seconds":1918,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/395-biotech-investors-plea-to-trump-and-a-busy-m-a-week/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/395-biotech-investors-plea-to-trump-and-a-busy-m-a-week.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"394: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy","slug":"394-eli-lilly-s-deal-man-allogene-s-off-the-shelf-car-t-and-merck-s-terns-buy","published_at":"2026-03-26T17:54:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/394-eli-lilly-s-deal-man-allogene-s-off-the-shelf-car-t-and-merck-s-terns-buy","url":"https://traffic.megaphone.fm/TTSAA4484091091.mp3?updated=1774548496","duration_seconds":1552,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/394-eli-lilly-s-deal-man-allogene-s-off-the-shelf-car-t-and-merck-s-terns-buy/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/394-eli-lilly-s-deal-man-allogene-s-off-the-shelf-car-t-and-merck-s-terns-buy.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"393: A conversation with the 'godfather' of biotech","slug":"393-a-conversation-with-the-godfather-of-biotech","published_at":"2026-03-20T14:23:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/393-a-conversation-with-the-godfather-of-biotech","url":"https://traffic.megaphone.fm/TTSAA2542570165.mp3?updated=1774024042","duration_seconds":2705,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/393-a-conversation-with-the-godfather-of-biotech/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/393-a-conversation-with-the-godfather-of-biotech.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"392: Epstein's pal attempts a biotech comeback, and Prasad exits the FDA","slug":"392-epstein-s-pal-attempts-a-biotech-comeback-and-prasad-exits-the-fda","published_at":"2026-03-12T17:42:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/392-epstein-s-pal-attempts-a-biotech-comeback-and-prasad-exits-the-fda","url":"https://traffic.megaphone.fm/TTSAA4013999142.mp3?updated=1773339038","duration_seconds":1851,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/392-epstein-s-pal-attempts-a-biotech-comeback-and-prasad-exits-the-fda/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/392-epstein-s-pal-attempts-a-biotech-comeback-and-prasad-exits-the-fda.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"391: Breaching the IBD efficacy ceiling, and sham surgeries","slug":"391-breaching-the-ibd-efficacy-ceiling-and-sham-surgeries","published_at":"2026-03-05T17:35:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/391-breaching-the-ibd-efficacy-ceiling-and-sham-surgeries","url":"https://traffic.megaphone.fm/TTSAA9607085727.mp3?updated=1772735911","duration_seconds":1829,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/391-breaching-the-ibd-efficacy-ceiling-and-sham-surgeries/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/391-breaching-the-ibd-efficacy-ceiling-and-sham-surgeries.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"390: FDA turmoil, election intrigue, AI, and more","slug":"390-fda-turmoil-election-intrigue-ai-and-more","published_at":"2026-02-26T18:53:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/390-fda-turmoil-election-intrigue-ai-and-more","url":"https://traffic.megaphone.fm/TTSAA2124962351.mp3?updated=1772132598","duration_seconds":1960,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/390-fda-turmoil-election-intrigue-ai-and-more/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/390-fda-turmoil-election-intrigue-ai-and-more.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"389: Hims' Super Bowl fallout, and the FDA reverses course","slug":"389-hims-super-bowl-fallout-and-the-fda-reverses-course","published_at":"2026-02-19T20:51:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/389-hims-super-bowl-fallout-and-the-fda-reverses-course","url":"https://traffic.megaphone.fm/TTSAA4438066659.mp3?updated=1771534813","duration_seconds":2060,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/389-hims-super-bowl-fallout-and-the-fda-reverses-course/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/389-hims-super-bowl-fallout-and-the-fda-reverses-course.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"388: The FDA's refusal to review Moderna's mRNA flu vaccine","slug":"388-the-fda-s-refusal-to-review-moderna-s-mrna-flu-vaccine","published_at":"2026-02-12T23:05:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/388-the-fda-s-refusal-to-review-moderna-s-mrna-flu-vaccine","url":"https://traffic.megaphone.fm/TTSAA7598338376.mp3?updated=1771001918","duration_seconds":3084,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/388-the-fda-s-refusal-to-review-moderna-s-mrna-flu-vaccine/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/388-the-fda-s-refusal-to-review-moderna-s-mrna-flu-vaccine.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"387: Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s","slug":"387-challenges-for-a-crucial-sickle-cell-treatment-and-the-latest-outlook-for-glp-1s","published_at":"2026-02-05T20:49:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/387-challenges-for-a-crucial-sickle-cell-treatment-and-the-latest-outlook-for-glp-1s","url":"https://traffic.megaphone.fm/TTSAA7740815504.mp3?updated=1770325297","duration_seconds":1684,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/387-challenges-for-a-crucial-sickle-cell-treatment-and-the-latest-outlook-for-glp-1s/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/387-challenges-for-a-crucial-sickle-cell-treatment-and-the-latest-outlook-for-glp-1s.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"From Drug Story: Lipitor and Heart Disease","slug":"from-drug-story-lipitor-and-heart-disease","published_at":"2026-02-03T10:00:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/from-drug-story-lipitor-and-heart-disease","url":"https://www.drugstory.co/p/episode-2-lipitor-and-heart-disease","duration_seconds":3696,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/from-drug-story-lipitor-and-heart-disease/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/from-drug-story-lipitor-and-heart-disease.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"386: The high stakes for Huntington's patients","slug":"386-the-high-stakes-for-huntington-s-patients","published_at":"2026-01-29T21:24:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/386-the-high-stakes-for-huntington-s-patients","url":"https://traffic.megaphone.fm/TTSAA4890848946.mp3?updated=1769722907","duration_seconds":2499,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/386-the-high-stakes-for-huntington-s-patients/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/386-the-high-stakes-for-huntington-s-patients.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}